个人简介
Giulio Belfiori 医生是 IRCCS 圣拉斐尔医院胰腺外科的主治医师,该科室由 Massimo Falconi 教授领导。
他于 2012 年以优异成绩毕业于安科纳的马尔凯理工大学医学与外科学专业,2018 年在同一所大学以优异成绩获得普通外科专业的专科医师资格。2016 至 2017 年间,他在德国马尔堡大学医院的腹部、胸部和血管外科工作。
Belfiori 医生的临床工作重点是胰腺、十二指肠、胆道和胆囊疾病的治疗,以及一般外科和腹壁/疝外科手术。他作为主刀医生完成了多例择期及急诊腹部手术,其中大多数为复杂手术,尤其是在胰腺外科领域,采用传统和微创技术进行操作。
他的研究方向包括胰腺腺癌、胰腺囊性肿瘤、壶腹部肿瘤和慢性胰腺炎。
他是 77 篇国际科学期刊论文的作者或合著者(H 指数:22),并经常参与国内外专业学术会议。
出版物
最新出版物
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival
Ann Surg Oncol. 2021 Dec;28(13):8249-8260. doi: 10.1245/s10434-021-10401-7. Epub 2021 Jul 13. PMID: 34258720.
Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
Surgery. 2021 Feb;169(2):403-410. doi: 10.1016/j.surg.2020.08.002. Epub 2020 Sep 8. PMID: 32912782.
Minimally Invasive Versus Open Treatment for Benign Sporadic Insulinoma Comparison of Short-Term and Long-Term Outcomes
World J Surg. 2018 Oct;42(10):3223-3230. doi: 10.1007/s00268-018-4628-4. PMID: 29691623.
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress
Nat Immunol. 2022 Oct;23(10):1470-1483. doi: 10.1038/s41590-022-01311-1. Epub 2022 Sep 22. PMID: 36138183.
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology
HPB (Oxford). 2021 Nov;23(11):1666-1673. doi: 10.1016/j.hpb.2021.04.004. Epub 2021 Apr 20. PMID: 33934960.
The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis
Ann Surg. 2021 Nov 1;274(5):721-728. doi: 10.1097/SLA.0000000000005132. PMID: 34353988.
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire. Surgery
2022 Oct;172(4):1202-1209. doi: 10.1016/j.surg.2022.04.036. Epub 2022 Jun 3. PMID: 35667898.
Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma
Ann Surg. 2022 Aug 1;276(2):378-385. doi: 10.1097/SLA.0000000000004464. Epub 2020 Oct 19. PMID: 33086324.
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS
Gastrointest Endosc. 2022 Oct;96(4):648-656.e2. doi: 10.1016/j.gie.2022.05.009. Epub 2022 May 23. PMID: 35618030.
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making
Ann Surg Oncol. 2022 May;29(5):3206-3214. doi: 10.1245/s10434-022-11326-5. Epub 2022 Jan 24. PMID: 35072863; PMCID: PMC8989932.
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study
Br J Surg. 2022 Jun 14;109(7):617-622. doi: 10.1093/bjs/znac103. PMID: 35511697.
Main Duct Thresholds for Malignancy Are Different in Intraductal Papillary Mucinous Neoplasms of the Pancreatic Head and Body-Tail
Clin Gastroenterol Hepatol. 2022 Feb;20(2):390-399.e7. doi: 10.1016/j.cgh.2020.12.028. Epub 2020 Dec 29. PMID: 33385536.
Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach
Cancers (Basel). 2021 Sep 30;13(19):4938. doi: 10.3390/cancers13194938. PMID: 34638421; PMCID: PMC8508250.
The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis
Ann Surg Oncol. 2021 Jun;28(6):3171-3183. doi: 10.1245/s10434-020-09310-y. Epub 2020 Nov 6. PMID: 33156465.
Defining Benchmark Outcomes for Pancreatoduodenectomy With Portomesenteric Venous Resection
Ann Surg. 2020 Nov;272(5):731-737. doi: 10.1097/SLA.0000000000004267. PMID: 32889866.